New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 3, 2014
11:15 EDTQUREuniQure announces analysis of six-year follow-up data for Glybera
uniQure announced the full analysis of the six-year follow-up data for patients treated once with Glybera, uniQure's gene therapy product for the treatment of lipoprotein lipase deficiency. Glybera is approved in the EU as a treatment for LPLD, a potentially life-threatening, orphan metabolic disease that results in patients' inability to process fat in the blood after a meal. LPLD patients eligible for Glybera treatment suffer from reoccurring and often severe pancreatitis events leading to recurrent admissions to hospitals and intensive care units.
News For QURE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 3, 2015
09:10 EDTQUREuniQure files $250M mixed securities shelf
Subscribe for More Information
February 23, 2015
07:22 EDTQURESunTrust to hold a conference
2015 Biotechnology and Pharmaceutical 1:1 Orphan Drug Day is being held in New York on February 23.
February 20, 2015
10:14 EDTQUREuniQure management to meet with Piper Jaffray
Subscribe for More Information
February 19, 2015
18:25 EDTQUREPiper Jaffray biotech analyst to hold analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use